• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

    25.57 +0.48 (+1.91%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,711,126
    Open 25.24
    Bid (Size) 25.43 (1)
    Ask (Size) 25.52 (74)
    Prev. Close 25.09
    Today's Range 24.88 - 25.65
    52wk Range 18.92 - 81.73
    Shares Outstanding 99,581,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Pfizer Is Buying Weight Loss Biotech Metsera. Here's Why Viking Therapeutics Shareholders May Be Cheering.
    Investors once speculated that Pfizer might consider acquiring Viking. 
    Via The Motley Fool
    Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’
    BTIG said Pfizer’s $7.3 billion Metsera acquisition sharpens its clinical updates and strategic optionality. 
    Via Stocktwits

    Performance

    YTD
    -37.8%
    -37.8%
    1 Month
    -7.3%
    -7.3%
    3 Month
    -3.5%
    -3.5%
    6 Month
    +5.9%
    +5.9%
    1 Year
    -58.5%
    -58.5%

    More News

    Read More
    Big Pharma's Epicenter Shift: Eli Lilly and the Reshaping of the Weight-Loss Drug Market
    Via MarketMinute
    Topics Economy Intellectual Property
    Viking Short Interest Hits 5-Year High After Weight-Loss Drug Stumble, But Retail Clings To Bullish Mood For Now
    Via Stocktwits
    6 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months
    Via The Motley Fool
    Topics Bankruptcy
    Biotech Breakouts: 3 Stocks With Massive Upside Potential
    Via MarketBeat
    Novo Nordisk Faces Headwinds: Competitive Pressures and Compounded Drugs Force Lowered Outlook
    Via MarketMinute
    Topics Economy Intellectual Property Law Enforcement
    Prediction: After a Tough Summer for Healthcare Stocks, These 2 Companies Can Make a Comeback
    Via The Motley Fool
    Topics ETFs
    Peering Into Viking Therapeutics's Recent Short Interest
    Via Benzinga
    Think It's Too Late to Buy This Leading Biotech Stock? Here's Why There's Still Time.
    Via The Motley Fool
    Jim Cramer Expects Palantir To Reach New All-Time High
    Via Benzinga
    Down 34%, Should You Buy the Dip on Viking Therapeutics?
    Via The Motley Fool
    Prediction: These 2 Biotech Stocks Could Double in the Next 5 Years
    Via The Motley Fool
    The Problem With Weight Loss Stocks
    Via The Motley Fool
    Topics Economy
    2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts
    Via The Motley Fool
    Why Viking Therapeutics Stock Popped Nearly 4% Today
    Via The Motley Fool
    Billionaire Stanley Druckenmiller Just Bought the Dip on This Beaten-Down GLP-1 Stock (Hint: It's Not Eli Lilly or Novo Nordisk)
    Via The Motley Fool
    Topics Economy World Trade
    Why Is Viking Therapeutics Stock Crashing, and Is It a Buying Opportunity?
    Via The Motley Fool
    Eli Lilly Scores Another Weight-Loss Win; Viking, Novo Stocks Slump
    Via Investor's Business Daily
    Viking Therapeutics: What's Next?
    Via The Motley Fool
    2 Biotech Stocks That Could Soar 21% and 245% According to Wall Street's Top Analysts
    Via The Motley Fool
    Benzinga Bulls And Bears: Sunrun, Newegg, Walmart — And Powell Offers Rate Cut Hope
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Here's Why Shares in Viking Therapeutics Crashed This Week
    Via The Motley Fool

    Frequently Asked Questions

    Is Viking Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
    Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
    The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
    What is the current price of Viking Therapeutics, Inc. - Common Stock?
    The current price of Viking Therapeutics, Inc. - Common Stock is 25.57
    When was Viking Therapeutics, Inc. - Common Stock last traded?
    The last trade of Viking Therapeutics, Inc. - Common Stock was at 09/26/25 04:00 PM ET
    What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
    The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.55B
    How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
    Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.